| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE | 3 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE | 2 | |
| Morphine | ACTIVE MOIETY | 76I7G6D29C | Morphine Sulfate 1 mg/mL in 5% Dextrose 100 mL Bag | 2 | |
| Morphine | ACTIVE MOIETY | 76I7G6D29C | Morphine Sulfate 2 mg/mL in 0.9% Sodium Chloride Syringe | 6 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | Morphine Sulfate 0.5 mg/mL in 0.9% Sodium Chloride 10 mL Syringe | 4 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | Morphine Sulfate 5 mg/mL in 0.9% Sodium Chloride 30 mL Monoject Syringe Barrel | 3 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | These highlights do not include all the information needed to use Morphine Sulfate Tablets safely and effectively. See full prescribing information for Morphine Sulfate Tablets. Morphine Sulfate Tablets, CII Initial U.S. Approval: 1984 | 1 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE ER - C-II 15 mg TABLETS | 1 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE ER - C-II TABLETS - 15MG, 30MG | 1 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | These highlights do not include all the information needed to use Morphine Sulfate Tablets safely and effectively. See full prescribing information for Morphine Sulfate Tablets. Morphine Sulfate Tablets, CII Initial U.S. Approval: 1984 | 2 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | These highlights do not include all the information needed to use Morphine Sulfate Tablets safely and effectively. See full prescribing information for Morphine Sulfate Tablets. Morphine Sulfate Tablets, CII Initial U.S. Approval: 1984 | 7 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | These highlights do not include all the information needed to use Morphine Sulfate Tablets safely and effectively. See full prescribing information for Morphine Sulfate Tablets. Morphine Sulfate Tablets, CII Initial U.S. Approval: 1984 | 2 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | Morphine Sulfate Extended-Release Tablets CII 15 mg 30 mg 60 mg 100 mg* 200 mg* | 2 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | AVINZA ® C II (morphine sulfate extended-release capsules) 30 mg, 45 mg, 60 mg, 75 mg, 90 mg, 120 mg R x Only | 1 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | a6b1858a-e796-4cb0-8a4d-d5c521874e84 | 1 | |
| MORPHINE | ACTIVE INGREDIENT | 76I7G6D29C | MORPHINUM 30C (Morphine Base) Rx Only | 1 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINUM 30C (Morphine Base) Rx Only | 1 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | Morphinum Muriaticum 30C (Morphine Hydrochloride) Rx Only | 1 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | These highlights do not include all the information needed to use Morphine Sulfate Oral Solution and Morphine Sulfate Tablets safely and effectively. See full prescribing information for Morphine Sulfate Oral Solution and Morphine Sulfate Tablets. Initial U.S. Approval: 1984 | 1 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE ER 60 MG | 359 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE EXTENDED-RELEASE TABLETS 15 mg, 30 mg, 60 mg, 100 mg*, 200 mg* CII Rx only *100 and 200 mg for use in opioid tolerant patients only | 2 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MS CONTIN® (morphine sulfate controlled-release) Tablets CII 15 mg 30 mg 60 mg 100 mg * 200 mg * | 1 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | 6c826b0a-ac87-48cc-a780-9a4a2118e8a8 | 1 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | CII Morphine Sulfate Extended-Release Tablets 15 mg, 30 mg, 60 mg, 100 mg* and 200 mg* | 5 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | dfe97a3d-247d-4dda-a641-1a95196cd8d8 | 1 | |
| morphine | ACTIVE MOIETY | 76I7G6D29C | DepoDur ® (morphine sulfate extended-release liposome injection) CII Rx Only | 5 | |
| morphine | ACTIVE MOIETY | 76I7G6D29C | AVINZA ® C II (morphine sulfate extended-release capsules) 30 mg, 60 mg, 90 mg, 120 mg R x Only | 1 | |
| Morphine | ACTIVE MOIETY | 76I7G6D29C | Morphine Sulfate Extended-Release Tablets C-II Rx only 30340-2 | 1 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE EXTENDED-RELEASE (MORPHINE SULFATE) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3678 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3674 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3612 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE ER (MORPHINE SULFATE) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3553 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3413 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3395 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3375 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3372 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | AVINZA (MORPHINE SULFATE) CAPSULE, COATED, EXTENDED RELEASE AVINZA (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3187 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE EXTENDED-RELEASE (MORPHINE SULFATE) TABLET [LAKE ERIE MEDICAL SURGICAL & SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3057 | |
| morphine | ACTIVE MOIETY | 76I7G6D29C | MS CONTIN (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 2084 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATEER ER (MORPHINE SULFATE) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 2008 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE TABLET [BRYANT RANCH PREPACK] | 1004 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | AVINZA (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | AVINZA (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | AVINZA (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 393 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE TABLET, EXTENDED RELEASE [QUALITEST PHARMACEUTICALS] | 21 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE SOLUTION, CONCENTRATE [LANNETT COMPANY, INC.] | 19 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE TABLET, EXTENDED RELEASE [MALLINCKRODT, INC.] | 19 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE SOLUTION [ROXANE LABORATORIES, INC] | 14 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 13 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | EMBEDA (MORPHINE SULFATE AND NALTREXONE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC] | 12 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 12 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE INJECTION, SOLUTION [HOSPIRA, INC.] | 11 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | AVINZA (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC] | 10 | |
| Morphine | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [UPSHER-SMITH LABORATORIES, INC.] | 10 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE SOLUTION [MALLINCKRODT, INC.] | 10 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.] | 10 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [ACTAVIS KADIAN LLC] | 9 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE SOLUTION [TRIS PHARMA INC] | 9 | |
| morphine | ACTIVE MOIETY | 76I7G6D29C | MS CONTIN (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [PURDUE PHARMA LP] | 9 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 8 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC] | 7 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [RHODES PHARMACEUTICALS L. P.] | 7 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [WATSON LABORATORIES, INC.] | 6 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [AMERICAN HEALTH PACKAGING] | 6 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 6 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 6 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.] | 6 | |
| Morphine | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 | |
| Morphine | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 5 | |
| Morphine | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE SOLUTION [VISTAPHARM INC.] | 5 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE TABLET [BRYANT RANCH PREPACK] | 5 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | OPIUM TINCTURE DEODORIZED (MORPHINE) SOLUTION [MARATHON PHARMACEUTICALS, LLC] | 5 | |
| MORPHINE | ACTIVE INGREDIENT | 76I7G6D29C | OPIUM TINCTURE DEODORIZED (MORPHINE) SOLUTION [MARATHON PHARMACEUTICALS, LLC] | 5 | |
| Morphine | ACTIVE MOIETY | 76I7G6D29C | ASTRAMORPH (MORPHINE SULFATE) INJECTION [ ASTRAZENECA LP] | 4 | |
| Morphine | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE (MORPHINE SULFATE ) INJECTION [INTERNATIONAL MEDICATION SYSTEMS, LIMITED ] | 4 | |
| Morphine | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 4 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE INJECTION, SOLUTION [HOSPIRA, INC.] | 4 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE SOLUTION [PADDOCK LABORATORIES, LLC] | 4 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE SOLUTION [QUALITEST PHARMACEUTICALS] | 4 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE TABLET [ROXANE LABORATORIES, INC] | 4 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 4 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 4 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | DURAMORPH (MORPHINE SULFATE) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 3 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 3 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | KADIAN ER (MORPHINE SULFATE) CAPSULE [ST MARYS MEDICAL PARK PHARMACY] | 3 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [PAR PHARMACEUTICAL INC.] | 3 | |
| Morphine | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE INJECTION [MERIDIAN MEDICAL TECHNOLOGIES, INC.] | 3 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 3 | |
| Morphine | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 3 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 3 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE ORAL SOLUTION SOLUTION MORPHINE SULFATE SOLUTION [CARACO PHARMACEUTICAL LABORATORIES, LTD.] | 3 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE SOLUTION [ATLANTIC BIOLOGICALS CORPS] | 3 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 3 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [WATSON LABORATORIES, INC.] | 3 | |
| MORPHINE | ACTIVE INGREDIENT | 76I7G6D29C | PAREGORIC LIQUID [HI-TECH PHARMACAL CO., INC.] | 3 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | PAREGORIC LIQUID [HI-TECH PHARMACAL CO., INC.] | 3 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 2 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [PAR PHARMACEUTICAL INC.] | 2 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 2 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE EXTENDED-RELEASE (MORPHINE SULFATE) TABLET [BRYANT RANCH PREPACK] | 2 | |
| Morphine | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE INJECTION [AMPHASTAR PHARMACEUTICALS, INC.] | 2 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 2 | |
| Morphine | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 2 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE INJECTION, SOLUTION [HOSPIRA, INC.] | 2 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE TABLET, EXTENDED RELEASE [AMERICAN HEALTH PACKAGING] | 2 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE TABLET, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS (USA) INC. ] | 2 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 2 | |
| MORPHINE | ACTIVE INGREDIENT | 76I7G6D29C | OPIUM TINCTURE DEODORIZED (MORPHINE TINCTURE) SOLUTION [ANI PHARMACEUTICALS, INC.] | 2 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | OPIUM TINCTURE DEODORIZED (MORPHINE TINCTURE) SOLUTION [ANI PHARMACEUTICALS, INC.] | 2 | |
| Morphine | ACTIVE MOIETY | 76I7G6D29C | OPIUM TINCTURE DEODORIZED (MORPHINE) TINCTURE [EDENBRIDGE PHARMACEUTICALS, LLC] | 2 | |